Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C. difficile infection

OBJECTIVES: The aim of this study was to evaluate the susceptibilities of Clostridium difficile isolates to cadazolid, a novel antibiotic for the treatment of C. difficile infection. METHODS: Ribotyping and susceptibilities were determined for C. difficile isolates from a multicentre, double-blind,...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerding, D. N., Hecht, D. W., Louie, T., Nord, C. E., Talbot, G. H., Cornely, O. A., Buitrago, M., Best, E., Sambol, S., Osmolski, J. R., Kracker, H., Locher, H. H., Charef, P., Wilcox, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681371/
https://www.ncbi.nlm.nih.gov/pubmed/26433782
http://dx.doi.org/10.1093/jac/dkv300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681371/
https://www.ncbi.nlm.nih.gov/pubmed/26433782
http://dx.doi.org/10.1093/jac/dkv300

Ejemplares similares